MSM
Research Reliability -
An organic sulfur compound that supports joint flexibility, reduces inflammation, and promotes healthy connective tissue.
Appetite
Mood
Sleep
MSM
Description
Methylsulfonylmethane (MSM) is an organosulfur compound that serves as a bioavailable source of sulfur, a key element in the cross-linking of collagen and keratin proteins that form connective tissue, skin, hair, and nails. It has anti-inflammatory properties, reducing cytokine production and modulating NF-kB signaling. Clinical trials show reductions in joint pain and stiffness in osteoarthritis, and it is frequently combined with glucosamine and chondroitin for synergistic joint support. MSM also supports post-exercise recovery by reducing muscle damage and oxidative stress from intense training.
Effects
First 2 weeks
subtle
Weeks 4–8
joint comfort and skin quality may improve
Ongoing
sulfur-based structural support
How it Feels
Gentle and gradual, with modest joint and skin benefits building over a month. A few people notice smoother skin or nails. It pairs commonly with glucosamine for a combined joint effect.
Usage
Entry Dose
500mg
Standard Dose
1000–3000mg
Max Dose
6000mg
Onset
4–8 weeks (joints/inflammation)
Combinations
Pairs well with
Synergistic
Glucosamine + chondroitin — complete joint support: building blocks + sulfur + inflammation control
Boswellia + curcumin — MSM provides sulfur for repair; botanicals reduce the inflammation
Vitamin C — C is required for collagen synthesis; MSM provides the sulfur component
Avoid combining
Contraindicated
Blood thinners — MSM may have mild antiplatelet effect; monitor if anticoagulated
No other major contraindications — generally well-tolerated across populations at standard doses
Biomarkers to Track
Subjective
(Daily)
Joint pain and stiffness (1–10)
Post-exercise soreness score
Skin and hair appearance
Objective
(Quarterly)
hs-CRP (inflammation marker)
Joint pain VAS score
Serum sulfate level (specialty)
Very safe and well tolerated.
Almost no one.
Expecting fast results, when skin and joint benefits are gradual.
Preliminary (limited / small human data)
Evidence comes from a small number of modestly sized trials.
Kim LS et al. (2006). Osteoarthritis and Cartilage. RCT (MSM and knee osteoarthritis). PMID: 16309928.